Bone marrow suppressing agents
    4.
    发明授权
    Bone marrow suppressing agents 失效
    骨髓抑制剂

    公开(公告)号:US4976950A

    公开(公告)日:1990-12-11

    申请号:US435096

    申请日:1989-11-13

    IPC分类号: A61K51/04

    CPC分类号: A61K51/0482 A61K2121/00

    摘要: The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, Holmium-166 and Yttrium-90 and at least one macrocyclic aminophosphonic acid ligand containing the 1,4,7,10-tetraazacyclododecane moiety, or a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.

    摘要翻译: 本发明涉及一种抑制骨髓的方法,其包括向哺乳动物施用选自钐-153,钆-159,钬-166和钇-90的至少一种放射性核素的骨髓抑制复合物和至少一种 含有1,4,7,10-四氮杂环十二烷部分的大环氨基膦酸配体或其生理上可接受的盐。 还提供了用于该方法的合适的组合物。

    Radiolabeled colloid compositions and method for preparing same
    10.
    发明授权
    Radiolabeled colloid compositions and method for preparing same 失效
    无定形胶体组合物及其制备方法

    公开(公告)号:US5061476A

    公开(公告)日:1991-10-29

    申请号:US458049

    申请日:1989-12-27

    CPC分类号: A61K51/1217 A61K2121/00

    摘要: Radiolabeled colloid compositions and a method for the preparation of radionuclide-colloid compositions useful in the treatment of rheumatoid arthritis are disclosed. A radionuclide selected from the group consisting of Sm-135, Ho-166, In-155m, Y-90, Gd-159 La-140, Lu-177, or Yb-175 is sorbed to a previously prepared iron-hydroxide colloid. The radiolabeled colloid compositions are comprised of spherical aggregations containing greater than 50% of the radioactive metal in iron-hydroxide particles. The method produces stable radionuclide iron-hydroxide compositions which are useful in therapeutic procedures such as radiation synovectomy.

    摘要翻译: 公开了放射性标记的胶体组合物和制备用于治疗类风湿性关节炎的放射性核素 - 胶体组合物的方法。 选自Sm-135,Ho-166,In-155m,Y-90,Gd-159 La-140,Lu-177或Yb-175的放射性核素吸附到预先制备的氢氧化铁胶体上。 放射性标记的胶体组合物由含有大于50%的氢氧化铁颗粒中的放射性金属的球形聚集体组成。 该方法产生稳定的放射性核素氢氧化铁组合物,其可用于诸如放射性滑膜切除术的治疗程序。